Variants in DNAJC13 Are Not Associated with Parkinson’s Disease Across Different Ancestral Backgrounds
Authors:
- Cesar Luis AvilaCACesar Luis Avila
- Mariam IsayanMIMariam Isayan
- Yasser MecheriYMYasser Mecheri
- Paula Saffie AwadPAPaula Saffie Awad
- Laurel A ScrevenLSLaurel A Screven
- Hampton L LeonardHLHampton L Leonard
- Maria Teresa PerinanMPMaria Teresa Perinan
- Kristin LevineKLKristin Levine
- Mary B MakariousMMMary B Makarious
- Global Parkinson's Genetics Program (GP2)G(Global Parkinson's Genetics Program (GP2)
Preprint
Abstract
Background: DNAJC13 was initially linked to autosomal dominant (AD) Parkinson’s disease (PD) in a European Mennonite family carrying the p.N855S variant. However, imperfect segregation and conflicting reports of pathogenicity raised uncertainty of DNAJC13 ’s role in the disease. Objectives: Explore the association between common and rare variants in DNAJC13 and Parkinson’s disease. Methods: We leveraged the largest available PD genetics data from the Accelerating Medicines Partnership - Parkinson Disease (AMP-PD) and the diverse ancestry available through the Global Parkinson’s Genetics Program (GP2), consisting of 2,471 patients and 3,098 controls, and 44,186 patients and 27,066 controls, respectively, to perform burden tests and association tests for rare and common variants, respectively. Results: Burden analysis showed no association between rare variants in DNAJC13 and PD. However, association analysis within common non-synonymous variants nominated 5 variants within DNAJC13 . Nevertheless, these associations require further validation since the analyses are still underpowered. Discussion: Our analysis did not find further evidence supporting DNAJC13 involvement in PD. However, studies of even larger cohorts and AD-PD families may bring definite answers about DNAJC13’s role in PD.Keywords
This publication has 28 references indexed in Scilit:
- Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's diseaseNeurobiology of Aging, 2021
- Receptor-mediated endocytosis 8 (RME-8)/DNAJC13 is a novel positive modulator of autophagy and stabilizes cellular protein homeostasisCellular and Molecular Life Sciences, 2020
- Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesThe Lancet Neurology, 2019
- DNAJC13 p.Asn855Ser, implicated in familial parkinsonism, alters membrane dynamics of sorting nexin 1Neuroscience Letters, 2019
- Utility and implications of exome sequencing in early‐onset Parkinson's diseaseMovement Disorders, 2018
- Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement DisordersJAMA Neurology, 2018
- DNAJC13 mutation screening in patients with Parkinson's disease from South ItalyParkinsonism & Related Disorders, 2018
- Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's diseaseNeurobiology of Aging, 2016
- Identification of TMEM230 mutations in familial Parkinson's diseaseNature Genetics, 2016
- DNAJC13 genetic variants in parkinsonismMovement Disorders, 2014